| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 797 | 2022 |
| WHO European regional obesity report 2022 World Health Organization World Health Organization. Regional Office for Europe, 2022 | 396 | 2022 |
| Excess all-cause mortality during the COVID-19 pandemic in Europe–preliminary pooled estimates from the EuroMOMO network, March to April 2020 LS Vestergaard, J Nielsen, L Richter, D Schmid, N Bustos, T Braeye, ... Eurosurveillance 25 (26), 2001214, 2020 | 254 | 2020 |
| COVID-19 in children: analysis of the first pandemic peak in England SN Ladhani, Z Amin-Chowdhury, HG Davies, F Aiano, I Hayden, J Lacy, ... Archives of disease in childhood 105 (12), 1180-1185, 2020 | 239 | 2020 |
| Risk of hospital admission for patients with SARS-CoV-2 variant B. 1.1. 7: cohort analysis T Nyberg, KA Twohig, RJ Harris, SR Seaman, J Flannagan, H Allen, ... bmj 373, 2021 | 157 | 2021 |
| Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season … R Pebody, F Warburton, J Ellis, N Andrews, A Potts, S Cottrell, J Johnston, ... Eurosurveillance 21 (38), 30348, 2016 | 157 | 2016 |
| Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017 LS Vestergaard, J Nielsen, TG Krause, L Espenhain, K Tersago, ... Eurosurveillance 22 (14), 30506, 2017 | 150 | 2017 |
| European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered? J Nielsen, LS Vestergaard, L Richter, D Schmid, N Bustos, T Asikainen, ... Clinical microbiology and infection 25 (10), 1266-1276, 2019 | 129 | 2019 |
| Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups HJ Whitaker, RSM Tsang, R Byford, NJ Andrews, J Sherlock, PS Pillai, ... Journal of Infection 84 (5), 675-683, 2022 | 114 | 2022 |
| COVID-19 Genomics UK (COG-UK) consortium. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of … KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... Lancet Infect Dis 22 (1), 35-42, 2022 | 114 | 2022 |
| Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies M Rondy, E Kissling, HD Emborg, A Gherasim, R Pebody, R Trebbien, ... Eurosurveillance 23 (9), 18-00086, 2018 | 97 | 2018 |
| End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17 R Pebody, F Warburton, J Ellis, N Andrews, A Potts, S Cottrell, A Reynolds, ... Eurosurveillance 22 (44), 17-00306, 2017 | 85 | 2017 |
| Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020 SK Nørgaard, LS Vestergaard, J Nielsen, L Richter, D Schmid, N Bustos, ... Eurosurveillance 26 (2), 2002023, 2021 | 79 | 2021 |
| SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July … AA Mensah, M Sinnathamby, A Zaidi, L Coughlan, R Simmons, SA Ismail, ... Journal of Infection 82 (4), 67-74, 2021 | 72 | 2021 |
| Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020 JL Bernal, N Panagiotopoulos, C Byers, TG Vilaplana, N Boddington, ... Eurosurveillance 27 (15), 2001551, 2022 | 68 | 2022 |
| All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England MA Sinnathamby, H Whitaker, L Coughlan, JL Bernal, M Ramsay, ... Eurosurveillance 25 (28), 2001239, 2020 | 68 | 2020 |
| Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known … M Joy, FDR Hobbs, JL Bernal, J Sherlock, G Amirthalingam, D McGagh, ... British Journal of General Practice 70 (701), e890-e898, 2020 | 59 | 2020 |
| End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18 R Pebody, A Djennad, J Ellis, N Andrews, DFP Marques, S Cottrell, ... Eurosurveillance 24 (31), 1800488, 2019 | 52 | 2019 |
| Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16 RG Pebody, MA Sinnathamby, F Warburton, N Andrews, NL Boddington, ... Eurosurveillance 23 (25), 1700496, 2018 | 47 | 2018 |
| Significant spike in excess mortality in England in winter 2014/15–influenza the likely culprit RG Pebody, HK Green, F Warburton, M Sinnathamby, J Ellis, K Mølbak, ... Epidemiology & Infection 146 (9), 1106-1113, 2018 | 45 | 2018 |
